Loading...
Loading...
Browse all stories on DeepNewz
VisitMajor Pharma Partnership Due to AlphaFold 3 by End of 2024?
Yes • 50%
No • 50%
Official press releases from Google, Isomorphic Labs, or partnering pharmaceutical companies
Google Launches AlphaFold 3, Expanding AI's Role in Drug Discovery
May 12, 2024, 04:10 PM
Google, in collaboration with Isomorphic Labs, has launched AlphaFold 3, an advanced AI model developed by Google DeepMind. This new version represents a significant step forward from its predecessor, AlphaFold 2, by expanding its capabilities to predict not only the 3D structures of proteins but also the interactions and structures of all biomolecules including DNA, RNA, and ligands. AlphaFold 3 is expected to revolutionize the field of drug discovery by providing detailed predictions of biomolecular structures, thereby enhancing the understanding of cellular mechanics and disease.
View original story
Drug discovery • 25%
Genetic research • 25%
Cancer research • 25%
Antibody development • 25%
Pharmaceuticals • 20%
Biotechnology • 20%
Cosmetics • 20%
Food and Beverage • 20%
Agriculture • 20%
North America • 25%
Europe • 25%
Asia • 25%
Rest of the World • 25%
Widely Adopted • 33%
Moderately Adopted • 34%
Rarely Adopted • 33%
RNA • 25%
Proteins • 25%
DNA • 25%
Ligands • 25%
Infectious Diseases • 25%
Cancer • 25%
Neurodegenerative Diseases • 25%
Genetic Disorders • 25%